DKK-TOA Profit Slumps on Lower Sales but Forecasts Operating Rebound for FY2027

PharmaVoiceFormer Ovid CEO Dr. Jeremy Levin’s rallying cry for biotech

Endpoints NewsM&A isn’t just for big pharma. Mid-size companies are stepping up deal hunts

LabiotechCAR-T therapy for stiff person syndrome nears approval

IlluminaHere Are Friday’s Top Wall Street Analyst Research Calls: Arista Networks, BWX Technologies, Cisco Systems, Danaher, Doximity, Estee Lauder, Illumina, Texas Roadhouse, Workday, and More - 24/7 Wall St.

Endpoints NewsAndrea Pfeifer ends 23-year reign at AC Immune; Acadia's top R&D exec announces retirement

Endpoints News#ASGCT26: A Zillow-like marketplace for abandoned gene therapies goes live

FierceBiotechAlumis pulls back from would-be rival to Amgen’s Tepezza after assessing prospects

LabiotechFreeze variability, not progress: strengthen your cell therapy supply chain from the start

Endpoints NewsSupreme Court preserves mail access for abortion pill

FierceBiotechAardvark to dig into phase 3 data early after FDA imposes hold

Siemens HealthineersSiemens Healthineers Wins Key US Clearances As Valuation Gap Widens - simplywall.st

BioNTechBioNTech’s Clinical and Corporate Overhaul: Cancer Data Improves as COVID Era Ends - AD HOC NEWS